Menu
Not yet recruiting NCT07441564

Evaluation of the Efficacy of Ischemic Preconditioning to Protect Against Acute Kidney Injury After Open Surgery for Juxtarenal Abdominal Aortic Aneurysm

No phase Interventional Aneurysm Aortic

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: patients with aortic clamping with preconditioning, patients with aortic clamping without preconditioning.
Who it may be relevant to
Registry conditions: Aneurysm Aortic. Basic parameters: 18 years — 85 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

Juxta-renal abdominal aortic aneurysms (AAA) are challenging to treat with standard endovascular techniques (EVAR) due to their proximity to the renal arteries. Open surgical repair continues to be used in patients unsuitable for EVAR but carries a high risk of acute kidney injury (AKI), up to 24%. Postoperative AKI is a strong predictor of both short- and long-term cardiovascular mortality. The KDIGO criteria are used to better define and stage AKI. Pharmacological prevention strategies have shown limited effectiveness, prompting interest in ischemic preconditioning (IPC). Remote IPC has shown mixed results in cardiac and vascular surgery, depending on patient risk and protocols used. Local IPC, applied directly near the renal arteries, has shown promising renal protection in animal models. However, this technique has never been clinically tested in humans. We propose here a randomized trial to assess the efficacy of local IPC before suprarenal aortic clamping during open repair of juxta-renal AAA to reduce postoperative AKI.

Interventions

  • Procedure patients with aortic clamping with preconditioning
    Experimental group (arm 1) consists of patients receiving open juxtarenal aortic aneurysm surgery with direct preconditioning by clamping the suprarenal aorta, which starts after randomization. The procedure for IPC will be achieved by two cycles of supra-renal aortic cross clamping during 5 minutes followed by an unclamping period of 5 minutes before starting the supra-renal aortic cross clamping needed to perform surgery. The level of aortic cross clamping used for IPC will be that required fo
  • Procedure patients with aortic clamping without preconditioning
    Control group (arm 2) consists of patients receiving open juxtarenal aortic aneurysm surgery without preconditionning

Primary outcome measures

  • To demonstrate the efficacy of ischemic preconditioning (IPC) applied closely to the supra-renal aorta with respect to the occurrence of Acute Kidney Injury (AKI) among patients undergoing open juxtarenal aortic aneurysm surgery. [Time frame: Day 8]

Eligibility criteria

Inclusion criteria

  • Patients aged 18-85 years
  • Patients with juxtarenal abdominal aortic aneurysms scheduled for open surgery
  • Patients with juxtarenal abdominal aortic aneurysms, which require suprarenal aortic cross clamping
  • Patients with juxtarenal abdominal aortic aneurysms, which are of atheromatous etiology or which developed after aortic dissection
  • Affiliation with, or beneficiary of a Social security (national health insurance) scheme
  • Adult having read and understood the information letter and signed the consent form
  • Women of childbearing potential with effective contraception according WHO definition (estrogen-progestin contraception or intrauterine device or male condom) since at least 1 month with a negative blood pregnancy test by b-HCG at inclusion.
  • Women surgically sterile (absence of ovaries and/or uterus or tubal ligation)
  • Postmenopausal women: confirmation of non-medically induced amenorrhea since at least 12 months prior to the inclusion visit

Exclusion criteria

  • Patients dependent from dialysis
  • Patients with aortic aneurysms, which require reconstruction of the visceral arteries
  • Patients with aortic aneurysms, which require supra-visceral aortic cross clamping
  • Patients with wall thrombus or calcification of inter- and suprarenal aorta
  • Patients with septic aortitis
  • Patients with aneurysm requiring stent graft (EVAR) explantation
  • Patients requiring emergency surgery
  • Patients receiving treatments that may interact with preconditioning: Nicorandil and Glibenclamide
  • Pregnant or parturient or breastfeeding woman or absence of proven contraception
  • Person deprived of liberty by an administrative or judiciary decision or person placed under judicial protection, under guardianship or curatorship
  • Person participating to another trial during the month before randomization
  • Medical history or psychological or sensorial abnormality prone to inhibit the subject to understand the conditions required for his/her participation to the protocol or unable to give an informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Other

Study locations

France · 7 centers
  • CHU de DIJON — Dijon
  • CHU de LILLE — Lille
  • CHU de NANCY — Nancy
  • CHU de NANTES — Nantes
  • Ap-Hp La Pitie — Paris
  • CHU de ROUEN — Rouen
  • CHU de TOULOUSE — Toulouse

Identifiers

NCT: NCT07441564 · 2023/0298/HP · 2024-A01808-39

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗